TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 4,583 | 4,570 | 3,960 |
Financial expenses | 117 | 148 | 174 |
Earnings before taxes | -60 | -17 | -17 |
EBITDA | 557 | 631 | 652 |
Total assets | 2,755 | 3,266 | 3,522 |
Current assets | 801 | 821 | 576 |
Current liabilities | 755 | 1,296 | 1,656 |
Equity capital | 391 | 451 | 468 |
- share capital | 100 | 100 | 100 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 14.2% | 13.8% | 13.3% |
Turnover per employee | 2,292 | 2,285 | 1,980 |
Profit as a percentage of turnover | -1.3% | -0.4% | -0.4% |
Return on assets (ROA) | 2.1% | 4.0% | 4.5% |
Current ratio | 106.1% | 63.3% | 34.8% |
Return on equity (ROE) | -15.3% | -3.8% | -3.6% |
Change turnover | 13 | 610 | -73 |
Change turnover % | 0% | 15% | -2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.